Drug recall · February 28, 2024
Clobazam Tablets 10mg recall
Why: CGMP Deviations: Out of specification for residual solvents.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Clobazam Tablets 10mg, 100-count bottle, Rx Only, Manufactured by: Micro Labs Limited Goa-403 722, India. Manufactured for: Micro Labs USA, Inc. Somerset, NJ 08873. NDC 42571-315-01
- Lots / codes
ZOAG043
- Quantity
- 24,768 bottles
- Company
- Micro Labs Limited, Verna, N/A
- Distribution
- Nationwide in the USA
- Initiated
- February 12, 2024 · Voluntary: Firm initiated
- Classified
- February 22, 2024
- Reported
- February 28, 2024
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Clobazam
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.